{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:26:17Z","timestamp":1791026777020,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,29]]},"DOI":"10.7759\/cureus.10122","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T19:45:50Z","timestamp":1598730350000},"source":"Crossref","is-referenced-by-count":1,"title":["Intrapleural Fibrinolytic Therapy Improves Results With Talc Slurry Pleurodesis"],"prefix":"10.7759","author":[{"given":"Alyssa","family":"Bellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Tarrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja H","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pleural Diseases","author":"Light RW","year":"2007","unstructured":"Light RW. Pleural Diseases. Lippincott Williams & Wilkins, Philadelphia; 2007."},{"key":"ref2","article-title":"Pneumothorax","author":"Burguete S","year":"2015","unstructured":"Burguete S, DeArmond D, Soni N, Peters J. Pneumothorax. Fishman\u2019s Pulmonary Diseases and Disorders. Grippi M, Elias J, Fishman J, et al. (ed): McGraw-Hill, New York; 2015. 5:"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002916.pub2","article-title":"Pleurodesis for malignant pleural effusions","volume":"1","author":"Shaw P","year":"2004","unstructured":"Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004, 1:10.1002\/14651858.CD002916.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010529.pub2","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"5","author":"Clive AO","year":"2016","unstructured":"Clive AO, Jones HE, Bhatnagar R, Preston NJ, Maskell N. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016, 5:10.1002\/14651858.CD010529.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III Intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler CM","year":"2005","unstructured":"Dresler CM, Olak J, Herndon JE, et al.. Phase III Intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005, 127:909-915. 10.1378\/chest.127.3.909","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(96)00808-9","article-title":"Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion","volume":"62","author":"Yim Ap","year":"1996","unstructured":"Yim Ap, Chan AT, Lee TW, Wan IY, Ho JK. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg. 1996, 62:1655-1658. 10.1016\/S0003-4975(96)00808-9","journal-title":"Ann Thorac Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2006.10.002","article-title":"Talc poudrage versus talc slurry in the treatment of malignant pleural effusion: a prospective comparative study","volume":"30","author":"Stefani A","year":"2006","unstructured":"Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion: a prospective comparative study. Eur J Cardiothorac Surg. 2006, 30:827-832. 10.1016\/j.ejcts.2006.10.002","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.01986.x","article-title":"Pleural controversy: pleurodesis versus indewelling pleural catheters for malignant effusions","volume":"16","author":"MacEachern P","year":"2011","unstructured":"MacEachern P, Tremblay A. Pleural controversy: pleurodesis versus indewelling pleural catheters for malignant effusions. Respirology. 2011, 16:747-754. 10.1111\/j.1440-1843.2011.01986.x","journal-title":"Respirology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087060","article-title":"Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis","volume":"9","author":"Xia H","year":"2014","unstructured":"Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One. 2014, 9:10.1371\/journal.pone.0087060","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3071","article-title":"Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas","volume":"142","author":"Janda S","year":"2012","unstructured":"Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas. Chest. 2012, 142:401-411. 10.1378\/chest.11-3071","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201608-594BC","article-title":"Safety and efficacy of tissue plasminogen activator and dnase for complicated pleural effusions secondary to abdominal pathology","volume":"14","author":"Majid A","year":"2017","unstructured":"Majid A, Ochoa S, Chatterji S, et al.. Safety and efficacy of tissue plasminogen activator and dnase for complicated pleural effusions secondary to abdominal pathology. Ann Am Thorac Soc. 2017, 14:342-346. 10.1513\/AnnalsATS.201608-594BC","journal-title":"Ann Am Thorac Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.30","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection","volume":"7","author":"Piccolo F","year":"2015","unstructured":"Piccolo F, Popowicz N, Wong D, Lee YC. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection. J Thorac Dis. 2015, 7:999-1008. 10.3978\/j.issn.2072-1439.2015.01.30","journal-title":"J Thorac Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9664","article-title":"Extended dwell time improves results of fibrinolytic therapy for complex pleural effusions","volume":"12","author":"Patino SH","year":"2020","unstructured":"Patino SH, Tarrazzi F, Tami C, Bellini A, Block M. Extended dwell time improves results of fibrinolytic therapy for complex pleural effusions. Cureus. 2020, 12:e9664. 10.7759\/cureus.9664","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2005.12.025","article-title":"The evidence on the effectiveness of management for malignant pleural effusion: a systematic review","volume":"29","author":"Tan C","year":"2006","unstructured":"Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006, 29:829-838. 10.1016\/j.ejcts.2005.12.025","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.527","article-title":"Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis","volume":"93","author":"Lorch DG","year":"1988","unstructured":"Lorch DG, Gordon L, Wooten S, Cooper JF. Strange C, Sahn SA. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest. 1988, 93:527-529. 10.1378\/chest.93.3.527","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.6.1763","article-title":"A comparison of rotation and nonrotation in tetracycline pleurodesis","volume":"104","author":"Dryzer SR","year":"1993","unstructured":"Dryzer SR, Allen ML, Strange C, Sahn SA. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest. 1993, 104:1763-1766. 10.1378\/chest.104.6.1763","journal-title":"Chest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0218492311410874","article-title":"Streptokinase for malignant pleural effusions: a randomized controlled study","volume":"19","author":"Okur E","year":"2011","unstructured":"Okur E, Baysungur V, Tezel C, Ergene G, Okur HK, Halezeroglu S. Streptokinase for malignant pleural effusions: a randomized controlled study. Asian Cardiovasc Thorac Ann. 2011, 19:238-243. 10.1177\/0218492311410874","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0612-0","article-title":"The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study","volume":"32","author":"Saydam O","year":"2015","unstructured":"Saydam O, Karapinar K, Gokce M, Kilic L, Metin M, Oz II, Tanriverdi O. The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study. Med Oncol. 2015, 32:179. 10.1007\/s12032-015-0612-0","journal-title":"Med Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000335419","article-title":"Mechanisms of pleurodesis","volume":"83","author":"Rodriguez-Panadero F","year":"2012","unstructured":"Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration. 2012, 83:91-98. 10.1159\/000335419","journal-title":"Respiration"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.6.pc09-00a","article-title":"Talc should be used for pleurodesis","volume":"162","author":"Sahn","year":"2000","unstructured":"Sahn, S. Talc should be used for pleurodesis. Am J Respir Crit Care Med. 2000, 162:2023-2024. 10.1164\/ajrccm.162.6.pc09-00a","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00037906","article-title":"Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis","volume":"28","author":"Marchi E","year":"2006","unstructured":"Marchi E, Vargas FS, Acencio MM, Antonangelo L, Genofre EH, Teixeira LR. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur Respir J. 2006, 28:929-932. 10.1183\/09031936.06.00037906","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38088-intrapleural-fibrinolytic-therapy-improves-results-with-talc-slurry-pleurodesis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:31Z","timestamp":1707506491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38088-intrapleural-fibrinolytic-therapy-improves-results-with-talc-slurry-pleurodesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.10122","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,29]]}}}